✦ LIBER ✦

Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy

✍ Scribed by Jørn Herrstedt; Hyman B. Muss; David G. Warr; Paul J. Hesketh; Peter D. Eisenberg; Harry Raftopoulos; Steven M. Grunberg; Munir Gabriel; Anthony Rodgers; Carolyn M. Hustad; Kevin J. Horgan; Franck Skobieranda; on behalf of the Aprepitant Moderately Emetogenic Chemotherapy Study Group

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 185 KB
Volume: 104
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.21343

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Herrstedt J, Muss HB, Warr DG, et al. Ef

Herrstedt J, Muss HB, Warr DG, et al. Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy. Cancer. 2005;104:1548–55.

📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 37 KB

Aprepitant for the prevention of chemoth

Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor types: a randomized, double-blind study

✍ Bernardo L. Rapoport; Karin Jordan; Judith A. Boice; Arlene Taylor; Carole Brown 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 174 KB

A randomized study of aprepitant, ondans

A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy

✍ Winnie Yeo; F. K. F. Mo; J. J. S. Suen; W. M. Ho; S. L. Chan; W. Lau; J. Koh; W. 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 184 KB

Efficacy and tolerability of transdermal

Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemotherapy: a randomized, double-blind, phase III study

✍ Ralph V. Boccia; Lucio N. Gordan; Gemma Clark; Julian D. Howell; Steven M. Grunb 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 185 KB

## Purpose A novel transdermal formulation of granisetron (the granisetron transdermal delivery system (GTDS)) has been developed to deliver granisetron continuously over 7 days. This double-blind, phase III, non-inferiority study compared the efficacy and tolerability of the GTDS to daily oral gra

Population pharmacokinetics of aprepitan

Population pharmacokinetics of aprepitant and dexamethasone in the prevention of chemotherapy-induced nausea and vomiting

✍ Susumu Nakade; Tomoya Ohno; Junsaku Kitagawa; Yoshitaka Hashimoto; Masahiro Kata 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 509 KB

Use of propofol for the prevention of ch

Use of propofol for the prevention of chemotherapy-induced nausea and emesis in oncology patients

✍ Corey S. Scher; David Amar; Robert H. McDowall; Samuel M. Barst 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 French ⚖ 227 KB